Cover Image

Editorial: Targeted Immunotherapy for Cancer

Saved in:

Bibliographic Details
Main Author:	Williams V. Williams (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Exploring immunotherapy targets and strategies for cancer: a multi-omics perspective
by: Wanchun Nie, et al.
Published: (2024)

Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021)

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more
by: Zhi-Bin Wang, et al.
Published: (2023)

Targeting the IL-9 pathway in cancer immunotherapy
by: Ningbo Zheng, et al.
Published: (2020)

Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy
by: Chunxue Zhang, et al.
Published: (2023)

Improving efficacy of cancer immunotherapy through targeting of macrophages
by: Elisa Peranzoni, et al.
Published: (2019)

Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer
by: Mei-Ye Li, et al.
Published: (2024)

Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
by: Aimin Jiang, et al.
Published: (2023)

Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment
by: Caroline P. Kerr, et al.
Published: (2022)

Targeting TIGIT for cancer immunotherapy: recent advances and future directions
by: Peng Zhang, et al.
Published: (2024)

Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer
by: Ilnaz Rahimmanesh, et al.
Published: (2021)

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
by: Yujeong Moon, et al.
Published: (2023)

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
by: Yanyan Xu, et al.
Published: (2022)

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
by: Bilal Zulfiqar, et al.
Published: (2022)

Targeting the Tumor Microenvironment for a More Effective and Efficient Cancer Immunotherapy
Published: (2020)

Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015
by: Robert A Bok
Published: (2008)

Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
by: Xianyanling Yi, et al.
Published: (2023)

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer
by: Xu Huang, et al.
Published: (2023)

Smart Nanocarriers for the Targeted Delivery of Therapeutic Nucleic Acid for Cancer Immunotherapy
by: Abu Baker, et al.
Published: (2023)

Editorial of special focus on melanoma immunotherapy
by: Ernesto Rossi
Published: (2022)

Editorial: Immunotherapy for hematological malignancies in children
by: Yusi Zhou, et al.
Published: (2023)

Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go?
by: Xuefeng Li, et al.
Published: (2022)

Immunotherapy Targeting Cytokines in Neuropathic Pain
by: Justin G Lees, et al.
Published: (2013)

Targeted lung cancer screening in the age of immunotherapies and targeted therapies - an economic evaluation for AustraliaResearch in context
by: Jacqueline Roseleur, et al.
Published: (2024)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
by: Peng X, et al.
Published: (2022)

mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
by: Kosuke Sasaki, et al.
Published: (2022)

The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer
by: Shay Sharon, et al.
Published: (2023)

Proteogenomic analysis identifies neoantigens and bacterial peptides as immunotherapy targets in colorectal cancer
by: Pengju Yao, et al.
Published: (2024)

Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task
by: Guoying Ni, et al.
Published: (2020)

Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
by: Seyed Hossein Kiaie, et al.
Published: (2021)

Advances in Polymeric Micelles: Responsive and Targeting Approaches for Cancer Immunotherapy in the Tumor Microenvironment
by: Lichun Cheng, et al.
Published: (2023)

In silico targeting of colony-stimulating factor-1 receptor: delineating immunotherapy in cancer
by: Zahra Azhar, et al.
Published: (2023)

Editorial: Chemosensitizing effect of natural products against cancers: Applications in enhancing chemotherapy and immunotherapy
by: Nand K. Roy, et al.
Published: (2022)

Editorial: Natural products modulate the sensitivity of cancer to anti-PD-1 based immunotherapy
by: Jean Christopher Chamcheu, et al.
Published: (2023)

Genetic Variants as Targets for Immunotherapy of Hematological Tumors
Published: (2020)

Regulatory T Cells: Potential Target in Anticancer Immunotherapy
by: Chi-Mou Juang, et al.
Published: (2007)

Targeting iNOS to increase efficacy of immunotherapies
by: Suhendan Ekmekcioglu, et al.
Published: (2017)

Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
by: Yonghyun Choi, et al.
Published: (2023)

Regulatory T cells in the tumour microenvironment of head and neck cancer: Emerging target in the era of immunotherapy
by: Chang Gon Kim, et al.
Published: (2022)

Immune Modulatory Effects of Molecularly Targeted Therapy and Its Repurposed Usage in Cancer Immunotherapy
by: Tiancheng Zhang, et al.
Published: (2022)